{"schema_version":"secwatch.filing_event.v1","accession":"0001801170-22-000090","form_type":"8-K","ticker":"CLOV","cik":"0001801170","company_name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","filed_at":"2022-11-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:52.173344+00:00","generated_at":"2026-06-21T11:45:47.115335+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Clover Health appoints Dr. Anna Loengard to Board of Directors","bullets":["Anna Loengard, M.D. appointed as Class I director effective November 28, 2022.","She will receive a pro-rata annual retainer and a pro-rated RSU award valued at $200,000.","Previously served as CMO of AccentCare, Caravan Health, and Queen's Healthcare System.","Her geriatric medicine and value-based care expertise supports Clover's in-home primary care strategy."],"urls":{"canonical":"https://secwatch.observer/filing/0001801170-22-000090","json":"https://secwatch.observer/filing/0001801170-22-000090.json","markdown":"https://secwatch.observer/filing/0001801170-22-000090.md","text":"https://secwatch.observer/filing/0001801170-22-000090.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1801170/000180117022000090/0001801170-22-000090-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1801170/000180117022000090/clov-20221128.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T11:45:47.115335+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"464a009eaf","claim":"Anna Loengard, M.D. was appointed as Class I director at CLOVER HEALTH INVESTMENTS, CORP. /DE.","evidence_excerpt":"On November 28, 2022, the Board of Directors (the \"Board\") of Clover Health Investments, Corp. (\"Clover\" or the \"Company\") appointed Anna Loengard, M.D., to serve as a Class I director of the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117022000090/0001801170-22-000090-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class I director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}